A Pilot, Single Centre, Prospective Clinical Study Investigation of the Acceptability of a Dedicated High Resolution Nuclear Breast Imaging Camera (MBI) in Breast Imaging of Patients Administered Tc-99m Sestamibi (ROSE)
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Lesions
Female
Breast Lesions
Trial Information
A Pilot, Single Centre, Prospective Clinical Study Investigation of the Acceptability of a Dedicated High Resolution Nuclear Breast Imaging Camera (MBI) in Breast Imaging of Patients Administered Tc-99m Sestamibi (ROSE)
Inclusion Criteria:
- females over 18 years of age
- completed a cardiac stress test using Tc-99m Sestamibi as the radiotracer prior to
MBI imaging on the same day.
- signed consent form
Exclusion Criteria:
- pregnant or lactating
- history of invasive breast cancer or ductal carcinoma in situ
- prior bilateral mastectomy
- prior breast biopsy or surgery within 3 months
- any other conditions that based on the investigator's judgement, may impact the
ability of the patient to complete the study
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Amit Singnurkar, MD, FRCPC
Investigator Role:
Principal Investigator
Investigator Affiliation:
HHSC, McMaster University, St. Joseph's Healthcare
Authority:
Canada: Health Canada
Study ID:
HHSC-CPDC-001
NCT ID:
NCT01368939
Start Date:
March 2012
Completion Date:
June 2013
Related Keywords:
- Breast Lesions
- breast imaging
- MBI
- dose reduction
- Tc-99m
- imaging
- cardiac
Name | Location |
|---|
